Drug Testing: Technologies and Global Markets

The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.

Report Includes

• An overview of the global market for drug testing technologies.
• Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
• An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
• Information on leading players in the market and their key products.
• Analysis of leading companies in the field and their successful strategies.

• The global market for DOA testing increased from $1.9 billion in 2007 to an estimated $2.0 billion by the end of 2008. It should reach $2.6 billion in 2014, for a compound annual growth rate (CAGR) of 4.6%.
• The U.S. testing market segment generated the largest share of revenues with $1.4 billion in 2007. This is expected to reach $1.5 billion in 2008 and $2.0 billion in 2014, for a CAGR of 5.2%.
• The European Union had the second largest market segment with $365.2 million in sales in 2007. This is expected to grow at a CAGR of 2.9% to reach $374.2 million in 2008 and $445.9 million in 2014.

• Drugs of abuse testing sales will reach $1.6 billion in 2007, rising at an AAGR (average annual growth rate) of 4.7%.
• Sales in the U.S. are expected to reach $996 million in 2002 and forecasted to grow to $1.3 billion in 2007 at an AAGR of 5.4%.
• Sales in Europe expected to be $291 million in 2002 and forecasted to grow at an AAGR of 1.8% to approximately $318 million in 2007.
• The number of different places and applications, such as a workplace, drug court, hospital, and school, for drug testing, with blood, hair, oral fluid, sweat or urine samples, reflects the need for a variety of drug testing services and the versatility of drug testing technology.